Clinical Trial Update: Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial update on ibudilast in progressive multiple sclerosis assessing safety, tolerability, and activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Drugs mentioned

• ibudilast (ibudilast)

Snippet

Sponsor: MediciNova | Conditions: Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive | Phase 2 | Status: COMPLETED | Results posted: 2020-07-28